Drawing based on the label description. No photo yet.
“Capsules: 50 mg light yellow opaque colour body and red opaque colour cap imprinted with "MN5" with black ink”
MN5 pill
Pill with imprint MN5 is yellow, capsule, 14 mm and has been identified as Nilotinib 50 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Novadoz Pharmaceuticals LLC.
Nilotinib 50 mg
- Imprint
- MN5
- Strength
- 50 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Yellow
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Novadoz Pharmaceuticals LLC
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 72205-237, 72205-237-92
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows MN5.
- It is yellow, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Nilotinib
Inactive: Silicon Dioxide, Crospovidone, Unspecified, Lactose Monohydrate, Magnesium Stearate, Poloxamer 188, Gelatin, Unspecified, Ferric Oxide Red, Ferric Oxide Yellow, Titanium Dioxide, Ferrosoferric Oxide, Propylene Glycol, Potassium Hydroxide, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
Y201 20mg
Duloxetine Hydrochloride 20 mg
Yellow, capsule, 14 mm
Used for nerve pain from diabetes and anxiety
-
SD TC 1 mg
Tacrolimus 1 mg
Orange & yellow, capsule, 14 mm
Used for eczema
-
G 583
Aprepitant 40 mg
White & yellow, capsule, 14 mm
Used for nausea and vomiting
-
G 685
Tacrolimus 0.5 mg
Yellow, capsule, 14 mm
Used for eczema
-
F 42
Atomoxetine 18 mg
White & yellow, capsule, 14 mm
Used for ADHD
-
AN 783
Memantine Hydrochloride 14 mg
Green & yellow, capsule, 14 mm
Used for Alzheimer's disease
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia